Xbrane Biopharma AB(DE:7XB0)
€0.88+0.00 (+0.23%)
DE:7XB0
Xbrane Biopharma AB earnings date
€0.88
At close:+0.00 (+0.23%)
Xbrane Biopharma AB (7XB0) Q2 2026 Earnings Report
6 Followers
DE:7XB0 Q2 2026 EPS Results
- Actual EPS
- -EUR 0.05
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- EUR 0.91
DE:7XB0 Q2 2026 Revenue Results
- Actual Revenue
- EUR 4.25M
- Expected Revenue
- EUR 2.63M
- Beat/Miss
- Beat by +EUR 1.61M
- YoY Revenue Growth
- +17.14%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 07/17/2026
- Time
- Before Open
- Conference Call
- Friday, July 17, 2026
DE:7XB0 Upcoming Earnings
Xbrane Biopharma AB's next earnings date is estimated for February 19, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:7XB0 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 19, 2027 | 2026 (Q4) | ―- | -0.12 | ― | ― |
| Oct 30, 2026 | 2026 (Q3) | ―-0.05 | -0.11 | 51.37% (+0.05) | |
| Jul 17, 2026 | 2026 (Q2) | ―-0.05 | 0.91 | -105.54% (-0.96) | |
| May 05, 2026 | 2026 (Q1) | -0.05-0.06 | 0.06 | -201.44% (-0.11) | |
| Feb 20, 2026 | 2025 (Q4) | -0.14-0.12 | -0.34 | 66.13% (+0.23) | |
| Oct 24, 2025 | 2025 (Q3) | 0.14-0.11 | -0.33 | 68.28% (+0.23) | |
| Aug 26, 2025 | 2025 (Q2) | 1.250.91 | -0.55 | 266.50% (+1.45) | |
| May 08, 2025 | 2025 (Q1) | -0.310.06 | -3.41 | 101.67% (+3.46) | |
| Feb 20, 2025 | 2024 (Q4) | 0.06-0.34 | -4.02 | 91.52% (+3.67) | |
| Oct 24, 2024 | 2024 (Q3) | -0.05-0.33 | -3.58 | 90.63% (+3.24) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

